Federal Funds Might Ease Cost Increases In States' Rx Assistance Programs
Executive Summary
The New Jersey PAAD drug assistance program has seen program costs increase by more than 20% over the past three years despite a decline in enrollment, Pharmaceutical Assistance to the Aged and Disabled Program Director Kathleen Mason said.
You may also be interested in...
Maine Rx Pricing Law Seeks FSS-Level Prices By October 2001
The "Maine Rx" discount law seeks Federal Supply Schedule-level rebates for prescriptions filled in Maine by October 2001.
Medicare Rx Block Grant Approach Viewed Skeptically By Penn. Gov. Ridge
State governors are wary of proposals to use a federal block grant approach to provide a prescription drug benefit for the elderly, Pennsylvania Gov. Thomas Ridge (R) told the Pharmaceutical Research & Manufacturers of America annual meeting April 15 in Laguna Niguel, Calif.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011